In8bio, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
INAB
In8bio, INCSCHEDULE: Fairbairn Family Reduces Stake in IN8bio
Emily and Malcom Fairbairn have fallen below the 5% beneficial ownership threshold in IN8bio, Inc. following a significant charitable donation of shares.
NASDAQ
INAB
In8bio, INCEmily and Malcom Fairbairn, along with their CRUT, increased their beneficial ownership in IN8BIO, INC. to 7.5% through a $1 million investment in a recent private placement.
NASDAQ
INAB
In8bio, INCBios Equity Partners and affiliated entities have amended their Schedule 13D filing for IN8BIO, INC., reporting a beneficial ownership of 4.0% of common stock following a warrant exchange and share sales.
NASDAQ
INAB
In8bio, INCSCHEDULE 13D/A: Bios Equity Partners Group Updates Stake in IN8bio, Consolidating Warrants and Injecting Capital
A group of investment funds led by Bios Equity Partners has updated its beneficial ownership in IN8bio, Inc. through a warrant exchange agreement, consolidating existing warrants and providing a cash payment.